The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sunitinib (SU) in patients with advanced, progressive pancreatic neuroendocrine tumors (pNET): Final overall survival (OS) results from a phase III randomized study including adjustment for crossover.
 
Eric Raymond
Honoraria - Ipsen; Novartis; Pfizer
Consulting or Advisory Role - Ipsen; Novartis; Pfizer
Research Funding - Ipsen; Novartis; Pfizer
 
Patricia Niccoli
No Relationships to Disclose
 
Daniel Castellano
No Relationships to Disclose
 
Juan W. Valle
Honoraria - Advanced Accelerator Applications; AstraZeneca; Celgene; Ipsen; Novartis; Sirtex Medical
Consulting or Advisory Role - Advanced Accelerator Applications; AstraZeneca; Celgene; Ipsen; Novartis; Sirtex Medical
Speakers' Bureau - Abbott Nutrition; Celgene; Ipsen; Novartis; Pfizer; Sirtex Medical
Research Funding - AstraZeneca (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Celgene; Novartis
 
Pascal Hammel
Honoraria - Celgene
Consulting or Advisory Role - AstraZeneca; Celgene; Merck Serono
Speakers' Bureau - Ipsen
Research Funding - Celgene (Inst); Merck Serono (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Ipsen; Merck Serono; Roche/Genentech
 
Jean-Luc Raoul
Consulting or Advisory Role - Bayer Schering Pharma; Celgene; Taiho Pharmaceutical; Transgene
Speakers' Bureau - Bayer Schering Pharma
 
Aaron Vinik
Honoraria - Merck; Pamlab
Consulting or Advisory Role - Isis Pharmaceuticals; Merck; Neurometrix; Pamlab; Pfizer
Speakers' Bureau - Merck; Pamlab
Research Funding - American Diabetes Association (Inst); Daiichi Sankyo (Inst); Impeto Medical (Inst); Intarcia Therapeutics (Inst); NIH (Inst); Novo Nordisk (Inst); Pfizer (Inst); Tercica (Inst); VeroScience (Inst); ViroMed (Inst)
 
Yung-Jue Bang
Research Funding - Pfizer (Inst)
 
Se-Hoon Lee
Honoraria - Pfizer
Consulting or Advisory Role - Pfizer
 
Ivan Borbath
Consulting or Advisory Role - Ipsen (Inst); Novartis (Inst)
Research Funding - Bayer (Inst); Ipsen (Inst); Pfizer (Inst)
 
Catherine Lombard Bohas
No Relationships to Disclose
 
Peter Metrakos
Consulting or Advisory Role - Bayer; Novartis
Research Funding - Bayer
Travel, Accommodations, Expenses - Bayer; Novartis
 
Denis Michel Smith
No Relationships to Disclose
 
Jen-Shi Chen
No Relationships to Disclose
 
Jean Francois Seitz
Honoraria - Amgen; Lilly; Merck Serono; Pfizer; Sanofi
Consulting or Advisory Role - Lilly; Sanofi
 
Shem Patyna
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
Consulting or Advisory Role - Pfizer
 
Xin Huang
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Jack Ishak
Employment - Novartis (I)
Research Funding - Various companies
 
Sandrine J. Faivre
Honoraria - Pfizer
Research Funding - Pfizer
 
Philippe B. Ruszniewski
Honoraria - Ipsen; Novartis; Pfizer
Consulting or Advisory Role - Ipsen; Novartis; Pfizer
Research Funding - Ipsen (Inst); Novartis (Inst)